
LinkedIn Posts
LinkedIn Posts
Aug 24, 2026
Our latest edition of Portfolio Profiles features MIAX, a leading operator of financial exchanges and execution services. Hear from Chairman and CEO Tom Gallagher and the Warburg Pincus team on how a tailored capital solution supported the company’s growth into a diversified, multi-asset exchange operator.
Go To Article
Aug 23, 2026
For three decades, we’ve had the privilege of partnering with entrepreneurs helping shape India’s growth story.
As part of our ongoing conversations on India’s next chapter, Vishal Mahadevia, Head of Asia Private Equity and Global Co-Head of Financial Services, and Narendra Ostawal, Head of India Private Equity, sit down with Avijit Saha, Managing Director & CEO of Vistaar Finance, to discuss the evolution of India’s private equity landscape, the opportunities ahead, and what it takes to build enduring businesses.
Go To Article
Aug 20, 2026
We are looking forward to seeing our colleague Brett Shawn participate in the Transaction Advisors Institute M&A Conference New York next month, sharing perspectives on how technology, disciplined governance, and standardized processes can help teams execute transactions with greater speed and efficiency.
Go To Article
Aug 19, 2026
Private equity firms are bringing a new playbook to the secondaries market.
In a recent conversation with PitchBook, Warburg Pincus Managing Directors and Partnership Solutions Co-Heads Andrew DiGeronimo and Vishnu Menon discuss the firm’s approach to the growing opportunity.
Go To Article
Aug 12, 2026
We are pleased to announce an expanded partnership with Kiō Investment Management, a leading Australian real asset investment manager, through an additional capital commitment to accelerate investment in build-to-rent and expand into purpose-built student accommodation across Australia’s key gateway cities.
Go To Article
Aug 10, 2026
We are pleased to present our Warburg Pincus 2026 Sustainability Report: Tested by Time. Aligned for This Moment. As the firm marks its 60th anniversary, this year’s report reflects on how sustainability is embedded in our culture and applied across our global investment platform.
Go To Article
Aug 6, 2026
Artificial intelligence is reshaping the technology landscape at an unprecedented pace, creating both disruption and significant opportunity.
In this edition of The Growth Blueprint, Mark Colodny, Managing Director, Co-Head of U.S. Private Equity and Chairman of Global Technology, and Justin Sadrian, Managing Director and Co-Head of U.S. Technology, discuss why this AI cycle is fundamentally different from previous technology shifts, what it means for software businesses, and how AI is accelerating value creation across the Warburg Pincus portfolio.
Go To Article
Jul 28, 2026
Congratulations to the BlackGen Capital team on another successful National Conference. We were proud to host this year’s event at Warburg Pincus and support a program dedicated to developing the next generation of finance leaders. It was a pleasure to have our CEO, Jeffrey Perlman, participate in the conference and share his perspective with attendees.
Go To Article
Jul 24, 2026
We are pleased to lead a significant investment in Paradigm Oral Health, a leading oral surgery and digital dentistry platform. The investment reflects a close collaboration between our Healthcare and Capital Solutions teams, bringing together deep sector expertise and flexible capital to help Paradigm continue building its differentiated platform.
Go To Article
Jul 15, 2026
That question sat at the heart of our discussion on regulating UK international competitiveness, with Andrew Sibbald, Managing Director, Head of Europe at Warburg Pincus, Lord David Willetts, Chair of the Regulatory Innovation Office, Michelle McCarthy Beck from the FCA and Joel Bamford from the CMA.
Go To Article
Jul 13, 2026
We are excited to lead a significant investment in PANTHERx Rare Pharmacy, the leading independent specialty pharmacy focused on rare diseases in the U.S. Our investment will support the continued growth of PANTHERx as a category-defining care platform, while preserving its patient-first, manufacturer-aligned model.
Go To Article